GCP
RPID icon

GSA Capital Partners’s Rapid Micro Biosystems RPID Stock Holding History

GSA Capital Partners’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,055
Closed -$74K – 1829
2022
Q3 		$74K Sell
23,055
-6,780
-23% -$26.3K 0.01% 1398
2022
Q2 		$128K Buy
+29,835
New +$139K 0.02% 1180

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

GSA Capital Partners's RPID Position: Q4 2022 in Review

GSA Capital Partners sold out of Rapid Micro Biosystems (RPID) in Q4 2022, closing a stake of 23,055 shares — an estimated $74K sold.

GSA Capital Partners first reported a position in RPID in Q2 2022 and held it in 2 quarters. The position peaked at $128K in Q2 2022. 42 funds tracked by Wall St. Rank hold RPID as of Q4 2022.

  • GSA Capital Partners reported no remaining Rapid Micro Biosystems position as of Q4 2022 after selling out during the quarter.
  • GSA Capital Partners sold 23,055 Rapid Micro Biosystems shares in Q4 2022, an estimated $74K.
  • GSA Capital Partners first reported a position in Rapid Micro Biosystems in Q2 2022 and held it in 2 quarters.
  • GSA Capital Partners's Rapid Micro Biosystems position peaked at $128K in Q2 2022.
  • 42 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q4 2022.

Based on GSA Capital Partners's 13F filing for Q4 2022, filed 13 Feb 2023.